•
Sep 30, 2012

Arrowhead Pharmaceuticals Q4 2012 Earnings Report

Total Revenue
$43.8K
Previous year: $291M
-100.0%
EPS
-$0.43
Previous year: -$0.39
+10.3%
Gross Profit
$43.8K
Cash and Equivalents
$3.38M
Previous year: $7.51M
-55.0%
Total Assets
$16.5M
Previous year: $15.9M
+4.0%

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals